Zuoxixing is a cell and gene therapy clinical product and therapy testing service provider, dedicated to cell and gene therapy clinical product and therapy testing and production services. The company develops clinical testing services for cell therapy platforms, viral vector platforms, mRNA vaccines and therapeutic platforms, and develops GMP-level production processes and process product quality control methods for plasmids and mRNAs, in order to speed up the process of gene cell therapy and mRNA drug research and development. contribute. Recently, Zuoxuan Biotech completed a new round of financing. The financing was exclusively invested by Matrix Partners, and the funds will be used to expand the GMP production and the upgrade and expansion of the safety testing and evaluation platform for cell gene therapy products.
This article is transferred from: https://www.itjuzi.com/investevent/13790607
This site is only for collection, and the copyright belongs to the original author.